CD274 and non-small cell lung carcinoma: We carried out a recent translational project quantifying the relative percentages in peripheral blood of CD4 and CD8 T cell differentiation subsets in NSCLC patients treated with anti-PD-1/PD-L1 immunotherapies [33].